Drug Pipeline

SCTC21C Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07297329 A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib… Multiple Myeloma (MM) Recruiting
NCT07388602 A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib… Amyloidosis Recruiting
Phase 1/2
NCT07538154 A Clinica Study of SCTC21C in Participants With Systemic Lupus Erythematosus Systemic Lupus Erythematosus (SLE) Not Yet Recruiting
Sponsors Running SCTC21C Trials
Sinocelltech Ltd. (3)
Disease Areas
Multiple Myeloma (1) Amyloidosis (1) Lupus (SLE) (1)
Get alerts when SCTC21C trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free